Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

EPILEPSIAE

Financiado

Cerrado

Evolving Platform for Improving Living Expectation of Patients Suffering from Ic...

Evolving Platform for Improving Living Expectation of Patients Suffering from IctAl Events Epilepsy is the commonest serious brain disorder in every country, and probably the most universal of all medical disorders. In Europe six million people currently have epilepsy and fifteen million will have epilepsy at some time... ver más

31/12/2011

UNIVERSIDADE DE CO...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

UNIVERSIDADE DE COIMBRA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 6 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2011-12-31 No tenemos la información de la convocatoria

0% 67% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

6 Participantes

UNIVERSIDADE DE COIMBRA

0.00€ | Lider

CNRS

N.D. | Participante

UKLFR

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

ESPS Epileptic Seizure Prediction System ESPS Predicting and... 71K€ Cerrado

SEIZSAFE Patient self adaptive system for detection recording and al... 856K€ Cerrado

DESARROLLO DE UNA TECNOLOGÍA INTEGRAL PARA EL... DESARROLLO DE UNA TECNOLOGÍA INTEGRAL PARA EL DIAGNÓSTICO PE... Rechazado

PID2020-119072RA-I00 DESARROLLO DE UN SISTEMA CLINICO DE MONITORIZACION EN TIEMPO... 121K€ Cerrado

EPINOSTICS Artificial Intelligence powered epilepsy diagnostics 3M€ Cerrado

PTQ-11-04960 Aplicabilidad de las nuevas tecnologías de secuenciación al... 95K€ Cerrado

Líder del proyecto

UNIVERSIDADE DE COIMBRA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Epilepsy is the commonest serious brain disorder in every country, and probably the most universal of all medical disorders. In Europe six million people currently have epilepsy and fifteen million will have epilepsy at some time of their lives. Currently nearly 30% of these people cannot be treated by therapeutics based on pharmacological anticonvulsive medication or resective surgery and are completely subjected to the sudden and unforeseen seizures strike that has a strong impact on their everyday life, with temporary impairments of motoricity, perception, speech, memory or conscience.Epilepsy costs the countries of Europe over 20 billion ECU every year, most of which related to the untreatable patients, an amount that could be significantly reduced with effective action.The project intends to develop an intelligent alarming system, transportable by the patient, measuring the brain dynamical activity, capable of predicting the seizures, allowing the patient to assess the risk of his actual situation and improving his safety The system is based on multisignal information (EEG, ECG and others), intelligent data processing and wireless communications.The project will develop knowledge (in data analysis), algorithms (of seizure prediction) and technologies (of data acquisition and wireless transmission) that integrated into an intelligent system will be an important step forward in economical affordable personal healthcare systems for neurological applications.A European Epilepsy Database, replicated in the three clinical partners, will also be built by the project, including all the available information about epileptic patients, allowing semantic mining based on multimodal, multisignal and multidimensional data.The EPILEPSIA consortium consists of seven partners from 4 countries: 3 academic, 3 clinics, 1 industrial SME company, covering the whole value chain from theoretical conception to market products and final users.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores